Novel Insights and Therapeutics for Parkinson’s disease

Parkinson’s disease is the essential growth driver of the worldwide Parkinsons disease therapeutics. Most mutations such as SNCA, PINK1, PARK2, PARK7, PLA2G6, FBXO7 and ATP13A2 are the rare cause of the disease and one particular mutation in LRRK2 has been found common in certain populations. The enzymatic function of the mitochondrial localized kinase PINK1 is thereby essential and delivers a fast production of Parkin from its uniform distribution in the cytoplasm to damaged mitochondria. Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The therapeutics of Parkinsons Disease includes designing a Clinical trial for Parkinson, Outcome of clinical trials in PSP, therapeutic options for mood, Cognition and Psychosis. Physical therapy cannot cure Parkinson’s disease but therapy can help to compensate the changes brought about by the condition, physical therapy can help with balance problems, fatigue, pain, weakness and sometimes local heat application is produced with high frequency to relieve muscle aches and pain.


  • Levodopa
  • Clinical trial for Parkinson,
  • Outcome of clinical trials in PSP
  • Therapeutic options for mood
  • Cognition and Psychosis

Related Conference of Novel Insights and Therapeutics for Parkinson’s disease

January 28-29, 2026

43rd International Conference on Women's Health

Bangkok, Thailand
February 16-17, 2026

11th World Congress on Public Health and Nutrition

Paris, France
March 09-10, 2026

6th International conference on Healthcare Summit

Paris, France
March 12-13, 2026

8th International Conference on Digital Health

London, UK
April 08-09, 2026

5th International Congress on Global Healthcare

Vienna, Austria
April 13-14, 2026

31st International Conference on Skincare and Cosmetology

Amsterdam, Netherlands
April 20-21, 2026

7th Global Summit on Digital Therapeutics

Barcelona, Spain
April 27-28, 2026

8th World Summit on Women's Health and Cancer Awareness

Vancouver, Canada
June 01-02, 2026

2nd International Congress on Primary Health and Safety

Zurich, Switzerland
June 15-16, 2026

8th World Conference on Vaccine and Immunology

Paris, France
July 13-14, 2026

13th World congress on Hospice and Palliative care

Amsterdam, Netherlands
July 23-24, 2026

37th European Heart and Heart Failure Congress

Paris, France
August 27-28, 2026

22nd Global Biomarkers and Clinical Research Summit

Paris, France
October 19-20, 2026

6th Euro-Global Summit on Probiotics & Nutraceuticals

Paris, France
December 16-17, 2026

7th Global Summit on Public Health

Amsterdam, Netherlands

Novel Insights and Therapeutics for Parkinson’s disease Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in